Medulloblastoma Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Medulloblastoma?
Medulloblastoma is a malignant tumour of the central nervous system (CNS). It develops in the cerebellum, which is located near the back of the brain.
Children and teenagers under the age of sixteen are primarily affected by medulloblastoma. It can happen to adults. However, it is less common in older people. Adults diagnosed with medulloblastoma often range in age from 20 to 45.
About 437 children and adults in the United States are affected by this uncommon form of cancer yearly. However, it is the most prevalent type of childhood brain tumour. Most cases are diagnosed between the ages of five and nine.
What is the Importance of Timely Treatment?
Early therapy is essential for medulloblastoma to improve survival rates, reduce tumour spread, and maintain brain function. Early management decreases recurrence risk and improves responses to chemotherapy, radiotherapy, and surgery. In addition to enhancing long-term results and quality of life for patients, early therapy also reduces the likelihood of cognitive and developmental deficits, especially in children. Treatment delays raise the possibility of metastases, brain damage, and decreased therapeutic efficacy.
What are the Common Symptoms of Medulloblastoma?
Your age, the size of the tumour, and its stage of development are some variables that can affect the symptoms of medulloblastoma. These symptoms could be caused by a pressure buildup inside your head or the tumour's location. Some warning signs are:
- Pain in the back
- Issues with balance
- Vision changes
- Having trouble walking
- Lightheadedness
- A headache
- Vomiting and feeling sick
- Fatigue
- Incontinence of the urine or bowel (accidents with peeing and pooping)
Causes and Risk Factors of Medulloblastoma
Causes
The underlying cause of medulloblastoma is not entirely known, but it is thought to include mutations in the most essential pathways, such as TP53, SHH, and WNT. Hereditary genetic syndromes, including Li-Fraumeni syndrome, neurofibromatosis type 1, and Gorlin syndrome, predispose individuals. Environmental influences, especially radiation exposure, might also contribute. Medulloblastoma occurs more frequently in young children, particularly in males, but in most cases, there is no known cause.
Risk Factors
Risk factors for medulloblastoma are:
- Age: Most often diagnosed between the ages of 3 to 8.
- Sex: Medulloblastoma is more likely to affect boys than girls.
- Genetic Syndromes: Hereditary disorders such as Li-Fraumeni syndrome, neurofibromatosis type 1, Gorlin syndrome, and Turcot syndrome raise the risk.
- Family History: Having a family history of medulloblastoma or other brain cancers may raise the risk.
- Radiation Exposure: Earlier radiation exposure, especially to the head, increases the risk of tumour forming.
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Medulloblastoma in India
The most recent studies of medulloblastoma, including those conducted by the Pacific Pediatric Neuro-Oncology Consortium (PNOC), focus on personalised treatment to the molecular profile of an individual tumour. This treatment attempts to enhance efficacy while reducing side effects.
Healthcare disparities, such as challenges in India, affect treatment, although survival rates are being addressed. New findings, including possibly targeting the KCNB2 gene, provide exciting avenues for more effective treatments. Progress is generally centred on personalised and targeted therapies to improve patient outcomes worldwide and in India.
Medulloblastoma Prevention Tips
- False
Treatment options for Medulloblastoma
Surgery: If feasible, surgical tumour removal is often the initial step. The goal is to remove as much of the tumour as safely as possible to decrease the likelihood of recurrence.
Radiation Therapy: Following surgery, radiation treatment is frequently employed in an attempt to kill any residual tumour cells. Young children have specific methods used to reduce the effect on immature brain tissue since radiation has long-term side effects.
Gamma Knife Radio Surgery: A non-surgical treatment for medulloblastoma, Gamma Knife radiosurgery is employed to treat residual cancer cells following surgery or for inoperable tumours.
Cost Start From USD 4000 - USD 7000Explore Options
Cyberknife treatment: CyberKnife is an outpatient medulloblastoma treatment that accurately delivers focused radiation to tumours without surgery. It is ideal for tumours that are inoperable or in difficult-to-reach locations.
Cost Start From USD 4500 - USD 7500Explore Options
Chemotherapy: agents eliminate residual cancer cells and lower the threat of metastasis. It is administered before and after surgery or as part of treatment in the high-risk population.
Cost Start From USD 600 - USD 700Explore Options
Magnetic Resonance Imaging (MRI) is the most frequent imaging method for detecting medulloblastomas. It can deliver high-quality pictures of the spinal cord and brain, allowing for the measurement of the tumour's size, location, and potential for spreading.
Computed Tomography (CT) Scan: If a facility does not have an MRI, a CT scan can be used. It detects the tumour's location and any swelling or bleeding in the brain.
Biopsy: A tissue sample of the tumour is removed during surgery (or in exceptional instances, by needle biopsy) to ensure that the tumour is a medulloblastoma. The biopsy can be examined histologically and genetically.
Lumbar Puncture (Spinal Tap): A lumbar puncture can be performed to examine the cerebrospinal fluid (CSF) for tumour cells, which would suggest metastasis to the spinal cord or other parts of the brain.
MediRehab (chain of Rehab centres - Part of MediGence) provides comprehensive rehabilitation services designed to support Medulloblastoma patients in India. These services include:
Physical Therapy (PT): For enhancing motor function, balance, and coordination, physical therapy enables patients to strengthen and become more independent, especially following surgery or radiation involving movement.
Occupational Therapy (OT): OT aims to assist patients with activities of daily living, such as dressing, eating, and writing, particularly if motor skills or fine motor functions are compromised.
Speech and Language Therapy: This therapy assists children and adults in regaining communication skills, including speech, language, and swallowing functions, which can be affected by surgery or radiation.
Cognitive Rehabilitation: Aspects of memory, attention, and problem-solving can be impacted by treatments for medulloblastoma, so cognitive rehabilitation seeks to enhance these abilities and may include specifically designed exercises to improve academic function and daily activities.
- Depending on the severity of the condition, your healthcare professional may prescribe medicine to help control your symptoms and support the treatment plan.
Instantly Connect with our Specialists
Hospitals for Medulloblastoma in India
American Oncology Institute
Hyderabad, India
American Oncology Institute located in Hyderabad, India is accredited by AAAHC. Also listed below are some of the most prominent infrastructural details:
- Equipped with the most advanced technology
- TruebeamStx + Calypso combination used for precise radiation therapy
- Backed by advanced equipment like 4D PET CT Imaging, Luminous Acupulse DUO laser, Rapid Arc, MRI, Brachytherapy, Digital Mammography
- Radiation oncology techniques- Intensity Modulated Radiation Therapy, Rapid Arc, Image-Guided Radiation Therapy,
- Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy
- All types of patient accommodation available which provide a comfortable stay to the patients & relatives.
- Fully equipped ICUs with the latest monitoring & therapeutic facilities for critically ill patients
- In house 24/7 blood bank for medical oncology service
- Well-designed patient rooms, therapy rooms OTs, consultation chambers, ICUs, walkways, lounges, parking
- Digital Breast Tomosynthesis is the breast imaging digital technology with 3D imaging
- Dedicated leukemia wing caters to the needs of the patients who are at a high risk of developing an infection
- State-of-the art PET CT, GE Discovery IQ 3 Ring16 PET with LightBurst technology
- Individual cabins for patients needing chemotherapy
- Friendly facility for differently-abled
- Exclusive outpatient consulting section
- Airport pick-up & drop
- Accommodation
- Currency exchange
- The estimated cost of treatment
- Language interpreters
- Payment
- Medical opinion
- Additional services
- Relationship manager
- Meals
- 24/7 Personal nurses*
- Visa assistance
The Madras Institute of Orthopedics and Traumatology
Chennai, India
MIOT started its journey with only 70 beds and focusing on Orthopedics and Trauma care. However, we grew into a multi-specialty hospital with time. MIOT is now a 1000-bedded hospital and can offer an extensive range of services across 63 specialties. The state of art laboratory of our hospital is ranked 8th internationally. We have 21 super-specialty operation theaters equipped with cutting-edge technology to help our doctors with complex procedures.
We take great care to make our patient rooms comfortable enough. The patient rooms get plenty of fresh air as well as natural light. The soothing views from the rooms do not let the patients feel cut off from the outside world. We use separate entrances for emergency patients, out-patients, in-patients, and their attendants. We put our patients’ safety first which is why we use a superior air system to ensure a near-zero infection healthy environment.
Apart from that, MIOT’s 24 hours blood bank provides all kinds of blood work related services which include blood collection to component separation. This state-of-art blood bank alone handles more than 30,000 units of blood over the course of a year. Every month around 600 blood transfusions are managed by this blood bank.
MIOT’s SIGNA Pioneer 3T MRI machine is made with noise reduction technology. This silent MRI machine can deliver superior quality neuroimages without wasting any time. The department of Radiology and Imaging Sciences can give tough competition to any international hospital with its advanced technology and accuracy.
The PET CT service at MIOT International is the first of its kind in South India enabling better and more accurate diagnosis than earlier. The superior diagnosis is also possible for the two digital cath labs at MIOT Heart Revive center.
We also have a physiotherapy team where a team of highly efficient physiotherapists deals with the mobility and functional disability issues of our patients. They listen to the patients carefully to identify the root of the pain and use therapeutic exercises to reduce their pain.
The CCU of MIOT is something to be proud of. The specially-trained staff of this unit is dedicated to ensuring top-quality medical support to serious patients. This unit along with the MIOT International Laboratory is the backbone of our facility.
Furthermore, what makes MIOT unique is our Telemedicine service. In the new normal, we are trying everything to reach our patients. Our one of its kind Telemedicine service connects our patients to our 250 full-time doctors over email, phone, chat and video consultations.
Sanar International Hospital
Gurugram, India
Sanar International Hospital is a multispeciality hospital based on Golf Course Road in Gurugram, a part of Delhi NCR. It was founded in 2018 and houses one of the most comprehensive and advanced surgical care specialties. This 150-bedded facility is committed to providing the best patient experiences and healthcare services is the core of the hospital’s mission. Staffed by a group of visionary and competent medical professionals who are well-versed in their fields and eminent for their empathy and understanding, Sanar International Hospital provides optimal care to its patients, making it a popular
Specialties in the Hospital such as Heart, Bone, and Joint neurosciences, Cancer, Kidney and Liver Transplant, and other successful procedures along with experienced medical professionals have made a mark for themselves among domestic patients and international patients who come to India to have the finest healthcare services. It follows strict international practices and believes that the centricity of the patient is essential for providing high-quality care through world-class infrastructure and state-of-the-art facilities. The technologies offered by the Hospital include Digital X-rays, MRI, CT, Ultrasound, transfusion medicine, pharmacy, laboratory services, 24 hrs emergency and ambulance services.
It offers more than 20 plus specialties such as General Medicine, Anesthesiology, Cardiac Sciences, Ophthalmology, Gastroenterology, Hematology, Orthopedics, General Surgery & Surgical, Cardiothoracic Surgery, Hepato Biliary Surgery, Pediatrics, Liver Transplantation, and Critical Care Medicine. The Hospital has a highly skilled medical staff of neuro-anesthetists, neurologists, specialized neurocritical care experts, neurosurgeons neuropsychologists, and neuropsychiatrists. There are specific centers for the treatment of epilepsy, stroke, brain tumors, movement disorders, spinal problems, and headaches.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Medulloblastoma Treatment?
India is growing in popularity as a place to treat medulloblastoma because of numerous essential benefits:
- Affordable Healthcare: Reduced costs of treatment relative to Western nations.
- World-Class Facilities: Cutting-edge medical equipment for diagnosis and treatment.
- Experienced Oncologists: Trained experts from the best global institutions.
- Cutting-Edge Treatments: Exposure to the newest treatments and clinical trials.
- Multidisciplinary Care: Holistic therapy by an expert team.
- Shorter Wait Times: Faster access to specialists.
Frequently Asked Questions
An essential treatment for medulloblastoma is radiation therapy, typically administered after surgery to target any remaining cancer cells and reduce the risk of recurrence. Since the tumour can spread through the cerebrospinal fluid, craniospinal irradiation (CSI) is often employed to treat the brain and spinal cord. For high-risk patients, radiation is crucial, but its application must be carefully managed, particularly in young children under three, to avoid long-term neurodevelopmental issues. When combined with surgery and chemotherapy, radiation improves survival rates and reduces the likelihood of relapse, although modern techniques aim to minimise side effects.
Medulloblastoma is often treated with chemotherapy, especially in high-risk pediatric cases. Chemotherapy is typically given after surgery and radiation therapy to target any remaining cancer cells and reduce the likelihood of recurrence. This approach is particularly important for enhancing the effectiveness of other treatments or for children who are too young to receive radiation. The combination of radiation, surgery, and chemotherapy improves overall survival rates and decreases the risk of relapse.
Factors such as age, tumour characteristics, and treatment response significantly determine the prognosis for medulloblastoma. Patients classified as high-risk tend to have a lower 5-year survival rate than those considered standard-risk, who typically have a survival rate of around 70–80%. While advancements in surgery, radiation, and chemotherapy have led to improved outcomes, challenges like relapse and long-term side effects remain prevalent. Early diagnosis and Individualized treatment plans are crucial for enhancing survival rates.
While medulloblastoma typically spreads within the central nervous system, it can also extend to other body areas. The cerebrospinal fluid (CSF) can move to various parts of the brain and spinal cord. Although less common, it can sometimes reach distant sites such as the lungs or bones. Early detection and treatment are essential to prevent this spread and improve outcomes.
A medulloblastoma tumour's molecular subgroup (WNT, SHH, Group 3, or Group 4) is based on its genetic makeup and influences therapy options. Although Group 3 needs more aggressive therapy, other subgroups, like WNT-driven tumours, are more favourable and may require less aggressive treatment. Genetic testing helps tailor therapy for better outcomes and fewer side effects.
The side effects of medulloblastoma treatment include fatigue, loss of mental function, hair loss, and coordination problems. Although radiation can affect growth and brain function, especially in very young children, surgery can lead to neurological issues. Hair loss, nausea, and a weakened immune system are all potential side effects of chemotherapy. Long-term effects include hearing loss, endocrine problems, and learning difficulties. While improvements in therapy diminish these adverse effects, they can still affect the quality of the patient's life.
With early diagnosis and treatment, medulloblastoma can be cured in most children in India. The tumour's size, type, and response to chemotherapy, radiation, and surgery all influence the likelihood of recovery. While survival is excellent for cases at average risk for relapse, long-term effects such as developmental challenges may need ongoing care and support. Regular follow-up is key to recovery management.
Medulloblastoma targets brain areas that control memory, learning, and movement, so it can affect neurological and intellectual function. Chemotherapy, radiation, and surgery can affect memory, concentration, and coordination. Tumor location and treatment can result in long-term cognitive impairment and delays in development, particularly in children.
The child's age, overall health, the nature of the treatment, and the characteristics of the tumour all influence the degree to which they recover after treatment for medulloblastoma in India. Children usually take a few months to several years to completely heal. Patients might initially require physical rehabilitation, have cognitive problems, and be tired. Side effects management, ongoing follow-up treatment, and support for learning or developmental issues are all needed for rehabilitation in the long run. Some children may take longer to recover, especially if they have complex treatment or if there are complications.